Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Lung Cancer Screening Registry and Quality Improvement Act of 2021 This bill establishes several grant programs and requirements for registries that collect data from lung cancer screenings with low-dose computed tomography (LDCT) under Medicare. (Currently, for purposes of Medicare coverage, radiology imaging facilities that furnish such LDCT screenings must report certain data to approved registries.) Specifically, the bill provides funds for FY2022-FY2026 for grants to help entities establish free registries, and requires registries to be interoperable in order to receive federal funds. The bill also provides grants to support the development of related quality measures for lung cancer screenings.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Health
AppropriationsCancerCardiovascular and respiratory healthDepartment of Health and Human ServicesExecutive agency funding and structureHealth care coverage and accessHealth care qualityHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesMedical tests and diagnostic methodsMedicare
Lung Cancer Screening Registry and Quality Improvement Act of 2021.
USA117th CongressHR-107| House
| Updated: 2/2/2021
Lung Cancer Screening Registry and Quality Improvement Act of 2021 This bill establishes several grant programs and requirements for registries that collect data from lung cancer screenings with low-dose computed tomography (LDCT) under Medicare. (Currently, for purposes of Medicare coverage, radiology imaging facilities that furnish such LDCT screenings must report certain data to approved registries.) Specifically, the bill provides funds for FY2022-FY2026 for grants to help entities establish free registries, and requires registries to be interoperable in order to receive federal funds. The bill also provides grants to support the development of related quality measures for lung cancer screenings.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
Health
Introduced
In Committee
On Floor
Passed Chamber
Enacted
AppropriationsCancerCardiovascular and respiratory healthDepartment of Health and Human ServicesExecutive agency funding and structureHealth care coverage and accessHealth care qualityHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesMedical tests and diagnostic methodsMedicare